Procter & Gamble Hygiene and Health Care Limited (PGHH)
🎯 Key Takeaways
- Procter & Gamble Hygiene and Health Care Limited is navigating a transitional phase marked by declining market performance and strategic financial management, with no active growth initiatives highlighted in recent disclosures. The company remains in a mature, cash-generating phase but faces headwinds reflected in its negative one-year return and elevated valuation multiples.
- ⚠️ Sustained underperformance in share price (-33% over 12 months) without a disclosed turnaround strategy.
📖 The Story
Procter & Gamble Hygiene and Health Care Limited is navigating a transitional phase marked by declining market performance and strategic financial management, with no active growth initiatives highlighted in recent disclosures. The company remains in a mature, cash-generating phase but faces headwinds reflected in its negative one-year return and elevated valuation multiples.
📰 What's Happening
Recent board activity has focused on capital return and compliance rather than operational expansion. On June 22, 2026, the company proposed a final dividend of ₹60 per share for FY 2025-26, pending shareholder approval at the upcoming AGM. This follows a pattern of consistent dividend policy, though payout levels must be weighed against earnings sustainability. Additionally, on June 19, 2026, a promoter group entity transferred 1.91% of equity through an on-market sale, though management confirmed no change in overall promoter control or governance structure.
Source: Stock Announcements
🔮 Management Outlook & What's Next
Management has not provided forward-looking operational guidance in the latest filings, focusing instead on procedural updates such as dividend approval timelines and TDS compliance for shareholders. The only forward-looking element is the upcoming AGM, where the ₹60 per share dividend will be voted on. No commentary on demand trends, product innovation, or market expansion was included in the recent disclosures.
Extracted from official company announcements. Not StockFin.ai's opinion.
⚖️ Peer Comparison — Personal Products
| Company | MCap (₹ Cr) | P/E | ROCE | ROE | D/E |
|---|---|---|---|---|---|
| Godrej Consumer Products Limited | 1.06 L Cr | -234.6 | — | — | — |
| Dabur India Limited | 82,955 | 46.1 | — | — | — |
| Colgate Palmolive (India) Limited | 58,749 | 44.3 | — | — | — |
| Procter & Gamble Hygiene and Health Care Limited | 31,506 | 36.7 | — | — | — |
| Gillette India Limited | 25,438 | 41.0 | — | — | — |
| Emami Limited | 18,684 | 23.6 | — | — | — |
| Cupid Limited | 16,184 | 668.7 | — | — | — |
| Honasa Consumer Limited | 11,518 | 145.1 | — | — | — |
| Bajaj Consumer Care Limited | 7,020 | 58.5 | — | — | — |
| JHS Svendgaard Laboratories Limited | 80 | -5.8 | — | — | — |
⚠️ Risk Factors
1. Sustained underperformance in share price (-33% over 12 months) without a disclosed turnaround strategy. 2. High P/E multiple (36.7) relative to negative price momentum, suggesting valuation may not reflect earnings quality. 3. Absence of growth drivers in management commentary raises concerns about long-term earnings visibility. 4. Dividend sustainability depends on uninterrupted cash flows, which are vulnerable if underlying demand weakens further.
📋 Recent Filings
-
Announcement 1 July 2026Procter & Gamble Hygiene and Health Care announced the appointment of Mr. Gopalakrishnan Kalianna as Sales Head effective August 1, 2026, succeeding M...
-
Financial Results 26 June 2026Procter & Gamble Hygiene and Health Care Limited announced that its trading window will close for directors and designated employees starting July 1, ...
-
regulation 31 23 June 2026Procter & Gamble Overseas India B.V. disclosed on April 2, 2026, that it holds 86,01,071 shares representing 51.82% of the paid-up share capital of Pr...
-
🟡 Board Meeting 22 June 2026PGHH proposed a final dividend of **₹60 per share** (face value ₹10) for FY 2025-26, pending shareholder approval at the upcoming AGM, with TDS compli...
-
🔴 Insider Trading 19 June 2026Procter & Gamble Hygiene and Health Care Limited disclosed that promoter group company Temple Trees Impex and Investment Pvt Ltd transferred 6,19,683 ...
-
Announcement 16 June 2026Procter & Gamble Hygiene and Health Care Limited presented its investor and analyst meeting on June 16, 2026, highlighting fiscal 2025-26 results with...
-
Announcement 16 June 2026Procter & Gamble Hygiene and Health Care Limited (PGHH) reported flat sales of ₹4,300 crores for FY2026 with 19% YoY PAT growth to ₹850 crores during ...
-
🔴 Announcement 15 June 2026No summary available
-
🟡 Board Meeting 12 June 2026No summary available
-
Announcement 3 June 2026Procter & Gamble Hygiene and Health Care Limited announced a virtual investor meeting scheduled for June 16, 2026 at 1:30 p.m. IST, inviting analysts ...
🧠 Analyst's Read
The company is currently in a defensive, income-focused phase with limited catalysts on the horizon. Investors should monitor upcoming AGM outcomes for dividend approval and any emerging commentary on demand trends or strategic initiatives. Until operational improvements or clearer growth signals emerge, the stock remains exposed to both earnings volatility and valuation compression.
Based on filing content and financial data. Not a recommendation.
Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-07-05.
📡 Get AI alerts when PGHH files new disclosures
Track PGHH filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track PGHH — FreeFree account · No credit card · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research